ArticleReproductive sciences (Thousand Oaks, Calif.)2026
Investigation of Endoplasmic Reticulum Stress in Pregnant Women with Hyperemesis Gravidarum.
Article in Reproductive sciences (Thousand Oaks, Calif.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The role of the endoplasmic reticulum (ER) stress response in hyperemesis gravidarum (HG) remains incompletely understood. This study evaluated circulating PERK and ATF-4 levels and their associations with clinical and laboratory characteristics in HG. This prospective case-control study, conducted from August to November 2024, included 85 pregnant women with HG within the first 16 weeks of gestation and 85 healthy pregnant controls. Serum PERK and ATF-4 levels were measured using ELISA. Group comparisons, Spearman correlation analyses, and receiver operating characteristic (ROC) analysis were performed. Serum ATF-4 levels were significantly lower in the HG group than in controls [4.55 (0.82-42.86) vs. 6.16 (2.23-29.27) ng/mL; p = 0.002], whereas PERK levels did not differ between groups [3.73 (0.16-15.37) vs. 3.29 (0.67-19.36) ng/mL; p = 0.965]. Strong positive correlations were observed between ATF-4 and PERK in the HG group (ρ = 0.837), control group (ρ = 0.709), and overall study population (ρ = 0.765) (all p < 0.001). Within the HG group, ATF-4 levels did not differ significantly according to urinary ketone positivity (p = 0.282). ATF-4 showed limited discriminatory performance for HG (AUC = 0.638; p = 0.001; sensitivity 45.9%; specificity 77.6%). HG is associated with lower circulating ATF-4 levels without a corresponding change in PERK. These findings support further molecular and longitudinal investigation of the PERK-ATF-4 axis in HG.
Indexed as
Identifiers
42870201What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.